Zobrazeno 1 - 10
of 15
pro vyhledávání: '"W. B. Frijlink"'
Autor:
W. B. Frijlink, H. Der Van Linden, K. Jie, J. P. Der Van Wey, C. J. L. M. Meijer, H. Mulder, E. De Vries, O. L. M. Bijvoet, J. Te Velde, H. C. Van Paassen, P. H. Reitsma
Publikováno v:
Arthritis & Rheumatism. 23:1193-1204
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127d294674c00db6047115708b794171
https://doi.org/10.1002/art.1780231018
https://doi.org/10.1002/art.1780231018
Publikováno v:
Metabolic Bone Disease and Related Research. 4:103-111
Bone scintigraphic results for 28 patients with Paget's disease treated with a combination of EHDP and calcitonin are reported. The uptake of the bone scintigraphic agent decreased considerably during the first year of treatment. There was good corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7535931fb6f6d2316cdedcc2a4d63f79
https://doi.org/10.1016/0221-8747(82)90023-6
https://doi.org/10.1016/0221-8747(82)90023-6
Autor:
C. J. L. R. Vellenga, O. L. M. Bijvoet, W. B. Frijlink, Jo Hermans, J. D. Mulder, Ernest K. J. Pauwels
Publikováno v:
Radiology. 153:799-805
We determined that the concentration of radioactivity in a lesion of Paget disease correlates with the grade of radiological deformation and the frequency of pain; the total skeletal uptake correlates with the severity of the biochemical abnormalitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c8e04fa24f2439bd08f06ae1458230
https://doi.org/10.1148/radiology.153.3.6494476
https://doi.org/10.1148/radiology.153.3.6494476
Publikováno v:
Metabolic Bone Disease and Related Research. 1:251-261
Thirty patients with Paget's disease were treated with a combination of EHDP and calcitonin. EHDP was given orally (7.5 mg/kg body weight/day) and calcitonin, either as synthetic human calcitonin 0.5 mg or as salmon calcitonin 50 or 100 MRC units day
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ed2673b88b88402d348ba68fbee6d3e
https://doi.org/10.1016/0221-8747(78)90010-3
https://doi.org/10.1016/0221-8747(78)90010-3
Autor:
W. B. Frijlink, Olav L. M. Bijvoet, Harm P. Sleeboom, Frans J. M. van Breukelen, Henk Mulder, Allan T. van Oosterom
Publikováno v:
Calcified Tissue International. 34:321-327
For 2 weeks 27 patients with hypercalcemia received a standard oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) as the sole agent. Results were grouped according to causes of hypercalcemia and compared with effects of APD i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3e11494ec15a5cfa359cb21279ed7cc
https://doi.org/10.1007/bf02411261
https://doi.org/10.1007/bf02411261
Publikováno v:
The Lancet. 313:799-803
18 patients with Paget's disease were treated orally with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.). In most cases bone resorption became normal within a week of treatment, whereas the return to normal bone formation took 3-6 months
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3a07561fd71929a9cd717ad2d59856e
https://doi.org/10.1016/s0140-6736(79)91318-7
https://doi.org/10.1016/s0140-6736(79)91318-7
Publikováno v:
Homeostasis of Phosphate and Other Minerals ISBN: 9781468477603
Diphosphonates are of pharmacological interest because they act on bone (1). In animals they decrease the performance of osteoclasts and of osteoblasts and can hinder the mineralization of osteoid (2,3,4). The first two properties have been used to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f2d4eb2dc31ebde0e80541c0354645e
https://doi.org/10.1007/978-1-4684-7758-0_47
https://doi.org/10.1007/978-1-4684-7758-0_47
Autor:
Olav L. M. Bijvoet, W. B. Frijlink, F. J. M. van Breukelen, F.J.F.E. Vismans, Pieter H. Reitsma
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461591696
Various bisphosphonates retard the growth and dissolution of hydroxyapatite crystals in vitro 1,2. Growth and remodeling of bone is associated with the transition of mineral between solution and crystalline phases. The possible actions of bisphosphon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe92b7aca8aebedc255ab0a454c79073
https://doi.org/10.1007/978-1-4615-9167-2_27
https://doi.org/10.1007/978-1-4615-9167-2_27
Autor:
Cees J. L R. Vellenga, Olav L. M. Bijvoet, H. I. J. Harinck, W. B. Frijlink, Ernest K. J. Pauwels
Publikováno v:
The British journal of radiology. 58(696)
Half-yearly bone scintigrams of 27 patients with Paget's disease, who were treated with the bisphosphonate APD, were evaluated. Uptake of "Tc m -Sn-EHDP was determined by computer analysis. All patients reached clinical and biochemical remission, usu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf5d95c5cc471a6e760bb19cd188f0d
https://pubmed.ncbi.nlm.nih.gov/3842627
https://pubmed.ncbi.nlm.nih.gov/3842627
Autor:
S. Adami, O. L. M. Bijvoet, S. E. Papapoulos, W. B. Frijlink, T. L. Clemens, J. L. H. O'Riordan
In 10 patients with Paget's disease of bone and 2 patients with osteoporosis, we studied the effects of hypocalcemia and hypophosphatemia induced by disodium-(3-amino-1-hydroxypropylidene)-1,-bisphosphonate (APD) treatment on the serum concentration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aee54baf78cbb4a26d600e0b7d7651f3
http://hdl.handle.net/11562/4908
http://hdl.handle.net/11562/4908